2,4-Dihydro-4[4-[4-[4-Hydroxyphenyl]-1-piperazinyl]Phenyl]-2-(1-Methylpropyl)-3H-1,2,4-Triazole-3-One

2,4-Dihydro-4[4-[4-[4-Hydroxyphenyl]-1-piperazinyl]Phenyl]-2-(1-Methylpropyl)-3H-1,2,4-Triazole-3-One 106461-41-0 98%

Price	Get Latest Price
Packge	1MT	1kg	5kg	10kg	25kg

Min. Order:1MT
Time:2024-03-07

Product Details

Product Name2,4-Dihydro-4[4-[4-[4-Hydroxyphenyl]-1-piperazinyl]Phenyl]-2-(1-Methylpropyl)-3H-1,2,4-Triazole-3-One
CAS No.106461-41-0
EINECS No.434-820-9
MFC22H27N5O2
MW393.48
AppearanceSolidOff-White Pale Brown
Melting point 177-179°C
storage temp. Sealed in dry,Room Temperature
Boiling point 587.9±60.0 °C(Predicted)
density 1.25±0.1 g/cm3(Predicted)

Company Profile Introduction

Apicore US LLC headquartered in New Jersey, USA, and its contract manufacturing organization, Apicore Pharmaceuticals Pvt Ltd (Gujarat, India) are dedicated to developing and manufacturing active pharmaceutical ingredients (APIs) at our facilities, located in Somerset, NJ and Gujarat, India for the worldwide pharmaceutical industry.

Apicore LLC, a wholly owned subsidiary of RK Pharma Inc (www.rkpharmainc.com), is a leading process R&D and API manufacturing service provider for the worldwide pharmaceutical industry. We offer a wide portfolio of services ranging from API’s for the generic industry to custom synthesis for early phase pharmaceutical research and branded products.

Our USFDA approved facilities in India (Visakhapatnam, Andhra Pradesh and Vadodara, Gujarat) are both equipped with state-of-the-art analytical and research capabilities.

While our worldwide network of locations seamlessly integrate with each other, each unit also independently houses a full suite of R&D, QA, QC, and Manufacturing Services. This facilitates a continuous real-time exchange of information, ideas, and data while eliminating redundancies and waste.